MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schiöth, H. B.
Right arrow Articles by Szardenings, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schiöth, H. B.
Right arrow Articles by Szardenings, M.

Vol. 54, Issue 1, 154-161, July 1998

Chimeric Melanocortin MC1 and MC3 Receptors: Identification of Domains Participating in Binding of Melanocyte-Stimulating Hormone Peptides

Helgi B. Schiöth, Philip Yook, Ruta Muceniece, Jarl E. S. Wikberg, and Michael Szardenings

Department of Pharmaceutical Pharmacology, Uppsala University, Uppsala, Sweden (H.B.S., P.Y., J.E.S.W., M.S.), and Laboratory of Pharmacology, Institute of Organic Synthesis, Riga, Latvia (R.M.)

The melanocortin receptors MC1 and MC3 are G protein-coupled receptors that have substantial structural similarities and bind melanocyte peptides but with different affinity profiles. We constructed a series of chimeric MC1/MC3 receptors to identify the epitopes that determine their selectivities for natural melanocyte peptides and synthetic analogues. The chimeric constructs were made by a polymerase chain reaction that used identical regions in or just outside transmembranes (TM) 1, 4, and 6 and divided the receptors into four segments. Saturation and competition studies on the expressed chimeric proteins indicate that TM1, TM2, TM3, and TM7 are involved in the subtype-specific binding of melanocyte peptides to these receptors. The results support the hypothesis that TM4 and TM5 may not contribute to the ligand-binding specificity of the MC receptors. This is the first report to describe the subtype-specific hormone-binding domains of the melanocortin receptor family.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
DiabetesHome page
N. Feng, S. F. Young, G. Aguilera, E. Puricelli, D. C. Adler-Wailes, N. G. Sebring, and J. A. Yanovski
Co-occurrence of Two Partially Inactivating Polymorphisms of MC3R Is Associated With Pediatric-Onset Obesity
Diabetes, September 1, 2005; 54(9): 2663 - 2667.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
P. Prusis, T. Lundstedt, and J. E.S. Wikberg
Proteo-chemometrics analysis of MSH peptide binding to melanocortin receptors
Protein Eng. Des. Sel., April 1, 2002; 15(4): 305 - 311.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics